Business Context and Reporting Period
Company: Bristol-Myers Squibb Company (BMY)
Filing Type: Form 8-K (Current Report)
Date of Report: October 27, 2021
Reporting Period: Third Quarter 2021
This filing serves as a notification that the Company issued an Earnings Press Release and supplemental information regarding its financial results for the third quarter of 2021. The filing incorporates by reference the press release, supplemental data, and investor presentation materials.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced exhibits (Exhibit 99.1 Press Release and Exhibit 99.2 Supplemental Information) which are incorporated by reference but not detailed in the body of this 8-K summary.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the text provided. It directs investors to the Earnings Press Release and Supplemental Information for a full analysis of operational and financial changes for the third quarter of 2021.
Guidance, Outlook, and Risks
- Management Commentary: The Company hosted a conference call and webcast on October 27, 2021, at 10:00 a.m. Eastern time to discuss financial and operating initiatives.
- Non-GAAP Measures: The investor presentation (Exhibit 99.3) includes non-GAAP financial information. Reconciliations to GAAP measures are available in the Supplemental Information (Exhibit 99.2).
- Regulatory Disclosure: The presentation materials are furnished under Regulation FD but are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor are they incorporated by reference into future filings unless specifically stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for specific Q3 2021 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 (Supplemental Information) for reconciliations between non-GAAP and GAAP financial measures.
- Consult Exhibit 99.3 (Presentation Materials) for management's outlook and strategic initiatives, noting that these materials are not legally "filed" under Section 18.
- Verify the availability of the presentation on the Company's website (www.bms.com), as the Company reserves the right to discontinue access at any time.